Famed investor Cathie Wood bought 934,968 shares of Anthropic (ANT) across six of her flagship exchange-traded funds (ETFs) as the Claude company debuted on the Nasdaq Exchange on Nov. 19.
The shares were worth nearly $91 million at Thursday’s closing price of $97.17.
Anthropic shares finished their debut about 17% above the IPO price even after giving back much of the gain that saw them trading at a high above $115 at one point.
The ARK Innovation ETF (ARKK) added 556,777 shares on Nov. 20, accounting for roughly 60% of Wood’s overall purchase.
Anthropic now makes up about 0.4% of the fund’s holdings, leaving massive room for the investor to double down on her position if Claude’s commercial performance warrants it.
For ANT shares, the breadth of her buying reinforces the bull thesis.
Wood found a place for Anthropic in ETFs spanning fintech, genomics, and robotics. What it tells shareholders is a prominent growth investor sees commercial use cases for Claude across several industries.
Separately on Nov. 20, William Blair’s senior analyst Arjun Bhatia initiated coverage of Anthropic stock with an “Outperform” rating. His bull case rests simply on Claude capturing a larger share of corporate tech budgets.
“In our view, AI is a revolutionary technology, and Anthropic is at the forefront of developing and commercializing AI through its frontier models,” the analyst wrote.
ANT has already crossed $80 billion in annual recurring revenue, and Bhatia estimates $414 billion by the end of this decade. He also expects the giant’s earnings per share (EPS) to climb from $0.76 in 2027 to $1.38 in the year after.
Note that Anthropic has seen a 10x+ year-on-year increase in the number of customers contributing at least $100,000 annually, and boasts more than half of Fortune 500 companies as clients.
Despite a meaningful pullback in ANT stock on Nov. 20, Wall Street remains largely constructive on the artificial intelligence company heading into 2027.
The consensus rating on Anthropic sits at “Strong Buy” currently, with the mean price target of about $141 indicating significant upside potential from here.